Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The ozone layer and metered dose inhalers

¹Institut de cardiologie et de pneumologie de l'Université Laval, Sainte-Foy, Canada. lpboulet@med.ulaval.ca

Canadian Respiratory Journal

|August 26, 1998

Summary

The Montreal Protocol is phasing out ozone-depleting chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs). New hydrofluoroalkane (HFA) inhalers offer safe and effective alternatives, requiring coordinated efforts for a smooth transition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Triple inhaled therapy in asthma: Beliefs, behaviours and doubts.

Pulmonary pharmacology & therapeutics·2024

Same author

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.

Allergy·2023

Same author

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

Clinical and translational allergy·2019

Same author

The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018

Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017

Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017

Area of Science:

Environmental Science
Respiratory Medicine
Public Health Policy

Background:

The stratospheric ozone layer protects life from harmful ultraviolet radiation.
Chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs) contribute to ozone depletion.
The Montreal Protocol mandates a global phase-out of CFCs.

Purpose of the Study:

To review the transition from CFC-containing MDIs to alternatives.
To highlight the safety and efficacy of new inhaler technologies.
To emphasize the need for coordinated global action.

Main Methods:

Review of scientific literature on ozone depletion and inhaler technologies.
Analysis of the Montreal Protocol's impact on pharmaceutical practices.
Assessment of alternative inhaler systems (powder and HFA-based).

Main Results:

Hydrofluoroalkane (HFA) inhalers are safe and effective alternatives to CFC-MDIs.
New inhaler technologies offer potential advantages over older CFC-MDIs.
The transition necessitates significant industry, government, and healthcare provider collaboration.

Conclusions:

The phase-out of CFC-MDIs is critical for ozone layer protection.
HFA inhalers represent a viable and effective alternative for respiratory patients.
Successful transition requires harmonized efforts in product availability, comparison, education, and public awareness.

Related Experiment Videos